نتایج جستجو برای: epidermal growth factor receptor egfr

تعداد نتایج: 1927332  

Journal: :Cancer research 1986
F X Real W J Rettig P G Chesa M R Melamed L J Old J Mendelsohn

Mouse monoclonal antibodies have been used to study the distribution of the epidermal growth factor receptor in human cultured cells and tissues. As expected, most epithelial cells expressed epidermal growth factor receptor (EGFr), whereas cells of hematopoietic origin were EGFr-. However, EGFr was found to be differentially expressed on cultured cells of neuroectodermal origin. Normal melanocy...

2016
Bhuminder Singh Graham Carpenter Robert J. Coffey

Seven ligands bind to and activate the mammalian epidermal growth factor (EGF) receptor (EGFR/ERBB1/HER1): EGF, transforming growth factor-alpha (TGFA), heparin-binding EGF-like growth factor (HBEGF), betacellulin (BTC), amphiregulin (AREG), epiregulin (EREG), and epigen (EPGN). Of these, EGF, TGFA, HBEGF, and BTC are thought to be high-affinity ligands, whereas AREG, EREG, and EPGN constitute ...

2016
Xu Yufen Song Binbin Chen Wenyu Liu Jialiang Yang Xinmei

Leptomeningeal metastasis (LM) is a terminal event in the development of non-small cell lung cancer (NSCLC). It has a poor prognosis with median survival of 1.9 months if untreated. The improvement of OS in NSCLC patients relatively increases incidence of LM. While current therapeutic options for LM are limited. Epidermal growth factor receptor-tyrosine kinase inhibitors are a class of small mo...

Journal: :Cell 2016
Mohammed Kaplan Siddarth Narasimhan Cecilia de Heus Deni Mance Sander van Doorn Klaartje Houben Dušan Popov-Čeleketić Reinier Damman Eugene A. Katrukha Purvi Jain Willie J.C. Geerts Albert J.R. Heck Gert E. Folkers Lukas C. Kapitein Simone Lemeer Paul M.P. van Bergen en Henegouwen Marc Baldus

The epidermal growth factor receptor (EGFR) represents one of the most common target proteins in anti-cancer therapy. To directly examine the structural and dynamical properties of EGFR activation by the epidermal growth factor (EGF) in native membranes, we have developed a solid-state nuclear magnetic resonance (ssNMR)-based approach supported by dynamic nuclear polarization (DNP). In contrast...

2014
Manuel Correia Viruthachalam Thiagarajan Isabel Coutinho Gnana Prakash Gajula Steffen B. Petersen Maria Teresa Neves-Petersen

The epidermal growth factor receptor (EGFR) is a member of the ErbB family of receptor tyrosine kinases. EGFR is activated upon binding to e.g. epidermal growth factor (EGF), leading to cell survival, proliferation and migration. EGFR overactivation is associated with tumor progression. We have previously shown that low dose UVB illumination of cancer cells overexpressing EGFR prior to adding E...

Journal: :Nature communications 2011
Thorsten Maretzky Astrid Evers Wenhui Zhou Steven L Swendeman Pui-Mun Wong Shahin Rafii Karina Reiss Carl P Blobel

The fibroblast growth factor receptor 2-IIIb (FGFR2b) and the vascular endothelial growth factor receptor 2 (VEGFR2) are tyrosine kinases that can promote cell migration and proliferation and have important roles in embryonic development and cancer. Here we show that FGF7/FGFR2b-dependent activation of epidermal growth factor receptor (EGFR)/ERK1/2 signalling and cell migration in epithelial ce...

Journal: :Nature communications 2014
Sharmistha Chakraborty Li Li Vineshkumar Thidil Puliyappadamba Gao Guo Kimmo J Hatanpaa Bruce Mickey Rhonda F Souza Peggy Vo Joachim Herz Mei-Ru Chen David A Boothman Tej K Pandita David H Wang Ganes C Sen Amyn A Habib

Epidermal growth factor receptor (EGFR) overexpression plays an important oncogenic role in cancer. Regular EGFR protein levels are increased in cancer cells and the receptor then becomes constitutively active. However, downstream signals generated by constitutively activated EGFR are unknown. Here we report that the overexpressed EGFR oscillates between two distinct and mutually exclusive mode...

Journal: :Oncology research and treatment 2016
Hermann Reichegger Wolfram Jochum Diana Förbs Claudia Hader Martin Früh

BACKGROUND Osimertinib (AZD9291, Tagrisso) is a potent, irreversible third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). CASE REPORT Our report demonstrates that osimertinib is able to inhibit the growth of a radiotherapy- and surgery-refractory EGFR T790M-positive brain metastasis in a patient with lung adenocarcinoma. CONCLUSION These data show that r...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید